CAMP
CAMP4 THERAPEUTICS CORPORATION
4.20
-0.13 (-3.00%)
52w low 2.90
7.75 high
26.8% of range
Financial Analysis
| Ratio | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Profitability | |||||
| Operating Margin | -- | -14,822.6% | -8,142.3% | -1,488.3% | |
| EBITDA Margin | -- | -14,343.1% | -7,882.2% | -1,441.5% | |
| Net Margin | -- | -14,083.1% | -7,943.4% | -2,298.5% | |
| FCF Margin | -- | -12,809.4% | -7,055.7% | -852.8% | |
| Returns | |||||
| Return on Equity | 57.0% | 39.8% | -82.0% | -168.5% | |
| Return on Assets | -43.1% | -89.7% | -66.1% | -68.2% | |
| Return on Inv Capital | 45.9% | 33.1% | -66.4% | -86.2% | |
| Liquidity | |||||
| Current Ratio | 10.62x | 5.13x | 6.92x | 7.35x | |
| Quick Ratio | 10.62x | 5.13x | 6.92x | 7.35x | |
| Cash Ratio | 10.47x | 4.92x | 6.67x | 7.06x | |
| Leverage | |||||
| Debt / Equity | -0.16x | -0.09x | 0.13x | 0.04x | |
| Equity Multiplier | -1.32x | -0.44x | 1.24x | 2.47x | |
| Efficiency | |||||
| Asset Turnover | 0.00x | 0.01x | 0.01x | 0.03x | |
| Op CF / Net Income | 0.87x | 0.90x | 0.88x | 0.37x | |
| Investment | |||||
| Capex / Revenue | -- | 193.7% | 67.6% | 8.0% | |
| R&D / Revenue | -- | 11,604.6% | 5,953.5% | 1,092.1% | |
| SG&A / Revenue | -- | 3,318.0% | 2,288.8% | 496.2% | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+436.5%